HeraMED is pleased to announce the appointment of Emily Slade as a Non-Executive Director, with immediate effect.
Throughout her executive career, Emily has gained broad experience across Legal and Business Affairs, Intellectual Property and Strategy, in a range of sectors including healthcare, logistics and technology. Emily has worked in a range of organisations from start-ups to SMEs as well as large public companies such as Ansell Limited.
Emily was most recently Head of Legal and Business Affairs at Rendr, a fulfilment technology company providing on demand delivery solutions and was previously Head of Legal at Deliveroo AU and Legal Counsel Asia Pacific at Ansell Limited.
HeraMED Chairman, Ron Weinberger said:
"Emily brings highly relevant experience to HeraMED at a time when the commercialisation of the HeraMED technology platform is gathering momentum, underpinned by a rapidly growing number of commercial partnerships across Australasia, USA, Europe, and Israel. “Throughout her career, Emily has gained significant experience in managing legal issues including, most relevantly, licence, supply and distribution agreements and the protection and capitalisation of intellectual property.”
Non-Executive Director, Emily Slade said:
“I am delighted to be joining the HeraMED Board and look forward to supporting the commercialisation of the unique and cutting edge HeraCARE technology.
Growing up as part of the Slade Health Group, I have gravitated towards the healthcare sector and startups throughout my career and have accrued a broad network which I hope can complement and support HeraMED’s commercialisation strategy. I am excited about contributing to the future of HeraMED through my role on the Board.”